Literature DB >> 25553368

Ischemia-reperfusion injury in kidney transplantation.

Chun-Cheng Chen1, William C Chapman1, Douglas W Hanto1.   

Abstract

Ischemia-reperfusion injury to the kidney is a complex pathophysiological process that has importance during transplantation as it affects graft function and survival. It starts with the physiological changes associated with the death of the donor, including the direct effects of hypoxia and metabolic stress. The injury continues through the organ procurement and preservation procedures. Upon reperfusion, the organ is then further damaged by a reactive inflammatory process which had been primed during the earlier injuries. Clinically, the damage from microvascular dysfunction and cytotoxic agents contributed by the immunologic response results in impaired graft function or graft loss. Recent advances in understanding the specific pathways involved in this injury have helped identify novel therapies. Nevertheless, ischemia-reperfusion injury continues to be a daunting problem even as these treatment strategies are being evaluated for clinical use.

Entities:  

Mesh:

Year:  2015        PMID: 25553368     DOI: 10.2741/722

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  8 in total

Review 1.  Biomarkers and Pharmacogenomics in Kidney Transplantation.

Authors:  L E Crowley; M Mekki; S Chand
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

2.  Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Authors:  Chao Hu; Long Li; Peipei Ding; Ling Li; Xiaowen Ge; Long Zheng; Xuanchuan Wang; Jina Wang; Weitao Zhang; Na Wang; Hongyu Gu; Fan Zhong; Ming Xu; Ruiming Rong; Tongyu Zhu; Weiguo Hu
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

3.  Impact of ultrasound examination shortly after kidney transplantation.

Authors:  Christoph Schwarz; Jakob Mühlbacher; Georg A Böhmig; Marin Purtic; Eleonore Pablik; Lukas Unger; Ivan Kristo; Thomas Soliman; Gabriela A Berlakovich
Journal:  Eur Surg       Date:  2017-02-16       Impact factor: 0.953

4.  One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.

Authors:  T Benkö; M Gottmann; S Radunz; A Bienholz; F H Saner; J W Treckmann; A Paul; D P Hoyer
Journal:  Int J Organ Transplant Med       Date:  2018-02-01

5.  Pretransplant BMI Significantly Affects Perioperative Course and Graft Survival after Kidney Transplantation: A Retrospective Analysis.

Authors:  Małgorzata Dobrzycka; Beata Bzoma; Ksawery Bieniaszewski; Alicja Dębska-Ślizień; Jarek Kobiela
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

6.  Pretransplant Serum Uromodulin and Its Association with Delayed Graft Function Following Kidney Transplantation-A Prospective Cohort Study.

Authors:  Stephan Kemmner; Christopher Holzmann-Littig; Helene Sandberger; Quirin Bachmann; Flora Haberfellner; Carlos Torrez; Christoph Schmaderer; Uwe Heemann; Lutz Renders; Volker Assfalg; Tarek M El-Achkar; Pranav S Garimella; Jürgen Scherberich; Dominik Steubl
Journal:  J Clin Med       Date:  2021-06-11       Impact factor: 4.241

Review 7.  Mesenchymal Stromal Cell Uses for Acute Kidney Injury-Current Available Data and Future Perspectives: A Mini-Review.

Authors:  Shani Zilberman-Itskovich; Shai Efrati
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

8.  Knockdown of ANGPTL2 Protects Renal Tubular Epithelial Cells Against Hypoxia/Reoxygenation-Induced Injury via Suppressing TLR4/NF-κB Signaling Pathway and Activating Nrf2/HO-1 Signaling Pathway.

Authors:  Heli Xiang; Wujun Xue; Yang Li; Jin Zheng; Chenguang Ding; Meng Dou; Xiaoyan Wu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.